WASHINGTON (AP) — When President Donald Trump's administration announced it would repurpose an old, generic drug as a new treatment for autism, it came as a surprise to many experts — including the physician who suggested the idea to the nation's top health officials.

Dr. Richard Frye told The Associated Press that he'd been talking with federal regulators about developing his own customized version of the drug for children with autism, assuming more research would be required.

"So we were kinda surprised that they were just approving it right out of the gate without more studies or anything," said Frye, an Arizona-based child neurologist who has a book and online education business focused on the experimental treatment.

It's another example of the haphazard rollout of the Trump adminis

See Full Page